Position in AZN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,280,686,266
-$34,339,607 QoQ
Shares Held
6,753,962
+1.3% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#33
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. AZN ranks #8 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
6,753,962 | $1,280,686,266 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,280,686,266 | 6,753,962 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,315,025,873 | 6,667,812 | Shares | Defined | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||